Journal article
The wearable cardioverter-defibrillator: current technology and evolving indications.
-
Reek S
Electrophysiology Service, Hirslanden Klinik Aarau, Aarau, Switzerland.
-
Burri H
Cardiology Service, University Hospital of Geneva, Geneva, Switzerland.
-
Roberts PR
Cardiac Rhythm Management, University Hospital Southampton, Southampton, UK.
-
Perings C
Cardiology, St Marien Hospital Luenen, Luenen, Germany.
-
Epstein AE
Cardiovascular Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
-
Klein HU
University of Rochester Medical Center, Heart Research Follow up Program, Rochester, NY, USA.
-
Lip G
-
Gorenek B
-
Sticherling C
-
Fauchier L
-
Goette A
-
Jung W
-
Vos MA
-
Brignole M
-
Elsner C
-
Dan GA
-
Marin F
-
Boriani G
-
Lane D
-
Blomström-Lundqvist C
-
Savelieva I
Show more…
Published in:
- Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. - 2017
English
The wearable cardioverter-defibrillator has been available for over a decade and now is frequently prescribed for patients deemed at high arrhythmic risk in whom the underlying pathology is potentially reversible or who are awaiting an implantable cardioverter-defibrillator. The use of the wearable cardioverter-defibrillator is included in the new 2015 ESC guidelines for the management of ventricular arrhythmias and prevention of sudden cardiac death. The present review provides insight into the current technology and an overview of this approach.
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://folia.unifr.ch/global/documents/182526
Statistics
Document views: 21
File downloads: